CSIMarket
 
The Chemours Company  (CC)
Other Ticker:  
 
 
Price: $27.1400 $0.49 1.839%
Day's High: $27.39 Week Perf: 3.91 %
Day's Low: $ 26.52 30 Day Perf: 1.88 %
Volume (M): 2,936 52 Wk High: $ 39.05
Volume (M$): $ 79,694 52 Wk Avg: $30.19
Open: $26.52 52 Wk Low: $15.10



 Market Capitalization (Millions $) 4,175
 Shares Outstanding (Millions) 154
 Employees 7,000
 Revenues (TTM) (Millions $) 6,004
 Net Income (TTM) (Millions $) -308
 Cash Flow (TTM) (Millions $) 79
 Capital Exp. (TTM) (Millions $) 302

The Chemours Company

The Chemours Company is a leading global provider of performance chemicals. We began operating as an independent company on July 1, 2015 (the Separation Date) after separating from E. I. du Pont de Nemours and Company (DuPont) (the Separation). Our company is comprised of three reportable segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. Our Titanium Technologies segment is the leading global producer of titanium dioxide (TiO2), a premium white pigment used to deliver whiteness, brightness, opacity and protection in a variety of applications. Our Fluoroproducts segment is a leading global provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. Our Chemical Solutions segment is a leading North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries.

Following the Separation, Chemours developed a Five-Point Transformation Plan to address changes to our organization, cost structure and portfolio of businesses. We have made considerable progress on our transformation plan throughout 2016, with additional cost reductions and growth targeted in 2017.
The objectives of our multi-year five-point transformation plan are to improve our financial performance, streamline and strengthen our portfolio and reduce our leverage by:


Reducing our costs through a simpler business model;


Optimizing our portfolio to focus on our businesses where we have leading positions;


Growing our market positions where we have competitive advantages;


Refocusing our investments by concentrating our capital expenditures on our core businesses; and


Enhancing our organization to deliver our values and support our transformation to a higher-value chemistry company.

In our Titanium Technologies segment, we have a long-standing history of delivering high-quality TiO2 pigment using our proprietary chloride technology. We are the largest global producer of TiO2, and our low-cost network of manufacturing facilities allows us to efficiently and cost-effectively serve our global customer base. During 2016, we further enhanced our operating cost advantage with the startup of our second production line at our Altamira, Mexico facility. Chemours is well positioned to remain one of the lowest cost TiO2 producers and continue to meet our customers’ growing needs around the world.


In our Fluoroproducts segment, we are one of two globally integrated producers making both fluorochemicals and fluoropolymers. In Fluorochemicals, we expect to see increased adoption of Opteon™, the world’s lowest global warming potential refrigerant, as governments around the world pass legislation that makes the use of low global warming potential refrigerants a requirement. Our fluoropolymers offerings provide customers with tailored products that have unique properties, including very high temperature resistance and high chemical resistance. We will continue to invest in research and development to remain a leader in these areas, and ensure that we are able to meet our customers’ needs as regulations change.


In our Chemical Solutions segment, we completed our strategic review of our portfolio in 2016, including the announced sales of the Beaumont Aniline facility, Clean & Disinfect business, and Sulfur products business, and ceased production at our Reactive Metals Solutions (RMS) facility in Niagara Falls, New York. We remain committed to retaining and improving our Mining Solutions business (previously known as Cyanides business) and the product lines at our Belle, West Virginia site.

This additional capacity will allow us to serve the growing demand for sodium cyanide in the gold mining industry in the Americas.
We will maintain our commitment to responsible stewardship and safety for our employees, customers and the communities where we operate. Meeting and exceeding our customers’ expectations while conducting business in accordance with our high ethical standards will continue to be a primary focus for our company as we continue to transform Chemours into a higher-value chemistry company.

 



   Company Address: 1007 Market Street Wilmington 19801 DE
   Company Phone Number: 773-1000   Stock Exchange / Ticker: NYSE CC
   


Customers Net Income fell by CC's Customers Net Profit Margin fell to

-25.13 %

5.3 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ASH   -0.42%    
CE        1.66% 
FMC        3.46% 
FUL   -0.18%    
HUN   -3.33%    
TROX        1.77% 
• View Complete Report
   



Business Update

The Chemours Company Reports Revenue Decrease and Net Income Contraction in Third Quarter 2023 Compared to Competitors, Highlights Need for Internal Review and Strategic Changes

Published Thu, Mar 7 2024 1:30 AM UTC

Chemours Provides Update on Internal Review and Reports Revenue Decrease in 3rd Quarter 2023 Compared to CompetitorsThe Chemours Company recently released an update on its internal review, which was overseen by the Audit Committee of the Board of Directors with the help of independent outside counsel. This review was initiated in response to an anonymous report made to the C...

Business Update

Chemours: Board Changes and Revenue Decline Pose Challenges Amidst Resilient Corporate Clients

Published Fri, Feb 16 2024 1:30 PM UTC

Chemours Announces Changes to its Board of Directors and Faces Challenges Amidst Revenue DeclineWILMINGTON, Del. - The Chemours Company (Chemours) (NYSE: CC), a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, has recently made two significant changes to its Board of Directors. Director Sandra Phillips Rogers has an...

The Chemours Company

Breaking: Shocking Plummet in Revenue Sends CC Spiraling During Last Fiscal Period



The Chemours Company, a global leader in the specialty chemicals industry, recently released its financial results for the third quarter of 2023. The report revealed a sharp decline in income and revenue compared to the previous year, as well as a significant decrease in net income and key inventory levels. These results raise concerns about the company's financial health and spark curiosity about the impact on its future performance.
Income Plunge:
During the third quarter of 2023, The Chemours Company experienced a notable decline in income. Compared to the same period last year, the income fell sharply by -91.45% to $0.13 per share, down from $1.52. However, it is important to note that earnings per share turned positive from $-2.52 in the previous reporting period. This reversal could suggest positive changes in the company's operations, but further analysis is required to assess the sustainability of this improvement.

The Chemours Company

The Chemours Company Reports Fiscal Shortfall Due to Weak Sales for Quarter Ending June 30, 2023



In recent financial results, The Chemours Company showed mixed performance, with a positive stock trend contrasting a concerning shortfall in earnings. This article aims to interpret the results and explore their potential impact on the company's future.
1. Decreased Earnings and Revenue:
For the fiscal interval ending June 30, 2023, The Chemours Company experienced a significant shortfall of $-2.52 per share, compared to $1.26 per share in the previous year. This decline in earnings was accompanied by a substantial drop in revenue, decreasing by -14.204% to $1.64 billion from $1.92 billion in the comparable period the previous year.

The Chemours Company

EPS Drops due to Weak Sales at in the January to March 31 2023 span

As an AI language model, I cannot provide financial, investment, or trading advice, and it is essential to consult with a professional financial advisor before making investment decisions.
Based on the details provided in the statement, it is clear that The Chemours Company had a rough start in the first quarter of 2023. With a decline of 12.925% year on year in revenue and a drop of 32.87% in net profit per share, the company's financial performance has evidently weakened. While there's a slight improvement from the previous quarter, it is still considerably lower than the corresponding period of the prior year.






 

The Chemours's Segments
 
 
• View Complete Report

The Chemours's Operating Statistics Decrease / Increase
       
Number of Domestic Operating Stores    Number of Domestic Operating Stores Growth   
Number of International Operating Stores   Number of International Operating Stores Decline   
Total Number of Operating Stores    Total Number of Operating Stores Growth   
Avg. Sales per Domestic Operating Store (Thousands $)   Avg. Sales per Domestic Operating Store (Thousands $) Decline   
Avg. Sales per International Operating Store (Thousands $)   Avg. Sales per International Operating Store (Thousands $) Decline   
Avg. Sales per Operating Store (Thousands $)   Avg. Sales per Operating Store (Thousands $) Decline   
Avg. Profit per Domestic Operating Store (Thousands $)   Avg. Profit per Domestic Operating Store (Thousands $) Decline   
Avg. Profit per International Operating Store (Thousands $)    Avg. Profit per International Operating Store (Thousands $) Growth   
Avg. Profit per Operating Store (Thousands $)   Avg. Profit per Operating Store (Thousands $) Decline   




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com